UPDATE: Leerink Swann Downgrades Sanofi Based on Low Visibility
October 18, 2013 at 12:14 PM EDT
In a report published Friday, Leerink Swann analyst Seamus Fernandez downgraded Sanofi (NYSE: SNY ) from Outperform to Market Perform and lowered the PT from €83 ($113.7142) to €80 ($109.6191) based on low visibility in the company's recovery. Fernandez noted that this valuation does not include Sanofi's €3B
